Study Completed

Acne vulgaris

Bayer Identifier:

Trial_305547

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study on efficacy of ethinylestradiol + cyproterone acetate in women with acne papulopustulosa

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Female

Age

16 - 35 Years

Trial summary

Enrollment Goal

1011

Trial Dates

November 2002 - November 2003

Phase

Phase 3

Could I Receive a placebo

N/A

Products

Diane 35 (EE/CPA, BAY86-5264)

Accepts Healthy Volunteer

N/A

Trial design

Multicenter, double-blind, randomized parallel group study on efficacy of 0.035 mg ethinylestradiol/2 mg cyproterone acetate and of 0.035 mg ethinylestradiol/2 mg cyproterone acetate in combination with 10 mg cyproterone acetate in comparison to triphasic ethinylestradiol/norgestimate over 6 cycles in women with acne papulopustulosa

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A